RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > Bloomberg: J&J Sold Unapproved Medical Device for Years Prior to Approval

Bloomberg: J&J Sold Unapproved Medical Device for Years Prior to Approval

Posted 21 March 2012 | By Alexander Gaffney, RAC 

Life sciences manufacturer Johnson & Johnson sold its now-controversial vaginal mesh implant for three years prior to being approved by the US Food and Drug Administration (FDA) in 2008, reports Bloomberg.

The unauthorized sale of the Prolift vaginal mesh implant product, manufactured by Johnson & Johnson's Ethicon unit, could place the 510(k) approval pathway under additional scrutiny.

The company marketed Prolift as early as 2005, reports Bloomberg, reasoning that it was substantially equivalent to the already-approved Gynecare Gynemesh.

FDA "disagreed with this assertion," said FDA press officer Morgan Liscinsky, when FDA learned of the device in 2007, but still approved the product under the 510(k) pathway in 2008.

The company is currently embroiled in hundreds of lawsuit over the devices, which plaintiffs claim caused injury to them. The revelation about the unapproved sales of Prolift, could make it considerably harder to settle or win some of the lawsuit, said Bloomberg.

Read more:

Bloomberg - J&J Sold Vaginal Mesh Implant Without U.S. Regulatory Approval


© 2022 Regulatory Affairs Professionals Society.